SEC reporting owner

ARMISTICE CAPITAL, LLC SEC insider disclosures

Explore ARMISTICE CAPITAL, LLC's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-12T05:54:58.330Z

Reporting owner CIK
0001601086
Issuers
21
Coverage
verified

Inspect this reporting owner's activity

Step 1 of 3

Issuer relationships

ARMISTICE CAPITAL, LLC: source evidence dated 2026-10-12T05:54:58.330Z.

Issuer
Avalo Therapeutics, Inc.
CIK
0001534120
Tickers
CERC, AVTX
Officer
No
Director
Yes
What you should see

The displayed owner or issuer and source fields identify the receipt to verify; keep reporting and availability dates separate.

Step 2 of 3

Which issuer and transaction does this person appear in?

Match the reviewed owner identity, issuer and transaction code. Directory eligibility does not turn every filing into a strategy signal.

What you should see

Use the linked SEC receipts and company profiles to verify what became public and when.

Step 3 of 3

Browse insider directory

Use the linked SEC receipts and company profiles to verify what became public and when.

Browse insider directory
What you should see

Keep reporting dates and units beside the answer, and inspect its original citations.

Issuer relationships

See the complete issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

Show the table · 21 rows, 5 columns

Scroll sideways to compare all columns. Select a heading to sort.

Avalo Therapeutics, Inc.0001534120CERC, AVTXNoYes
DYNATRONICS CORP0000720875DYNTNoNo
VICAL INC0000819050VICLNoNo
ALIMERA SCIENCES INC0001267602ALIMNoNo
EYEGATE PHARMACEUTICALS INC0001372514EYEGNoYes
Del Frisco's Restaurant Group, Inc.0001415301DFRGNoNo
PAIN THERAPEUTICS INC0001069530PTIENoNo
APRICUS BIOSCIENCES, INC.0001017491APRINoNo
Valeritas Holdings Inc.0001619250VLRXNoNo
BIO-PATH HOLDINGS INC0001133818BPTHNoNo
AYTU BIOPHARMA, INC0001385818AYTUNoYes
ACHIEVE LIFE SCIENCES, INC.0000949858ACHVNoNo
ReShape Weightloss Inc.0001371217RSLS, RSLSDNoNo
AMAG PHARMACEUTICALS, INC.0000792977AMAGNoNo
INNOVUS PHARMACEUTICALS, INC.0001411879INNVNoNo
Onconova Therapeutics, Inc.0001130598ONTXNoNo
Vaxart, Inc.0000072444VXRTNoYes
TETRAPHASE PHARMACEUTICALS INC0001373707TTPHNoYes
TENAX THERAPEUTICS, INC.0000034956TENXNoYes
Cyclo Therapeutics, Inc.0000922247CTDHNoNo
ReShape Lifesciences Inc.0001427570RSLSNoNo

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

Show the table · 0 rows, 6 columns

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.

Aurora · AI research assistant

Try this in Aurora

Edit the request, then open it in Aurora. You choose when to send it.